Abstract
Objective
To estimate the proportion and risk factors of non-thyroidal illness (NTI) in children with congenital heart disease (CHD) with congestive heart failure (CHF).
Methods
This study enrolled children (6 weeks to 60 months age) with CHD and CHF. The clinical profile and disease severity, derived from the Pediatric Early Warning Score (PEWS) was recorded. Baseline blood samples were taken within 24 hours of hospitalization and evaluated for free tri-iodothyronine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH), N-terminal pro-brain natriuretic peptide (NT pro-BNP) and reverse T3.
Results
A total of 80 (64 acyanotic CHD) children of median (interquartile range) age 5 (2.5, 8.0) months were enrolled. NTI was seen in 37 (46%) of whom 27 had low fT3 levels. The proportion of NTI was highest in children with severe disease (20/30), than moderate (4/9) or mild disease (13/41) (p=0.018). Ten (27%) patients with NTI died compared to 2 (4.7%) without NTI with unadjusted odds ratio (OR) [95% confidence interval (CI)] 7.593 (1.54, 37.38); p=0.006. After adjusting for NTI, shock and NT-pro-BNP levels, PEWS was the only significant predictor of mortality (OR: 1.41, 95% CI: 1.03, 1.92; p=0.032). Linear regression for fT3 identified a significant relationship with log NT-BNP [beta -3.541, (95% CI: -1.387, -0.388)] and with TSH [beta 2.652 (95% CI: 0.054, 0.383)]. The cutoff (area under the curve, 95% CI) that predicted mortality were fT4 < 14.5 pmol/L (0.737, 0.60, 0.88), fT3/rT3 index < 1.86 pg/ng (0.284, 0.129, 0.438) and NT pro-BNP > 3725 pg/mL (0.702; 0.53, 0.88).
Conclusion
NTI was present in a significant proportion of children with CHD and CHF. fT3 level was significantly associated with NT-BNP levels and thus severity of CHF.
Keywords: Non-thyroidal illness, free T3, reverse T3, NT pro-BNP, Pediatric Early Warning Score
Read the full text
5 sections · 1 figure · 4 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Wang B, Liu S, Li L, Yao Q, Song R, Shao X, Li Q, Shi X, Zhang JA. Non-thyroidal illness syndrome in patients with cardiovascular diseases: A systematic review and meta-analysis. Int J Cardiol 2017;226:1-10. Epub 2016 Oct 18
Yadav Y, Saikia UK, Sarma D, Hazarika M. Cardiovascular Risk Factors in Children and Adolescents with Subclinical Hypothyroidism. Indian J Endocrinol Metab 2017;21:823-829.
Gloss B, Trost S, Bluhm W, Swanson E, Clark R, Winkfein R, Janzen K, Giles W, Chassande O, Samarut J, Dillmann W. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor alpha or beta. Endocrinology 2001;142:544-550.
Barjaktarovic M, Korevaar TIM, Gaillard R, de Rijke YB, Visser TJ, Jaddoe VWV, Peeters RP. Childhood thyroid function, body composition and cardiovascular function. Eur J Endocrinol 2017;177:319-327. Epub 2017 Jul 19
Jacobs A, Derese I, Vander Perre S, van Puffelen E, Verstraete S, Pauwels L, Verbruggen S, Wouters P, Langouche L, Garcia Guerra G, Joosten K, Vanhorebeek I, Van den Berghe G. Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management. Thyroid 2019;29:480-492. Epub 2019 Mar 11
Razvi S. Novel uses of thyroid hormones in cardiovascular conditions. Endocrine 2019;66:115-123. Epub 2019 Oct 15
Halsall DJ, Oddy S. Clinical and laboratory aspects of 3,3’,5’-triiodothyronine (reverse T3). Ann Clin Biochem 2021;58:29-37. Epub 2020 Nov 4
Sayarifard F, Yaghmaie B, Sayarifard A, Sayarifard A, Mohammadpour M, Sharifzadeh M, Abbasi F, Taghi Haghi-Ashtiani M, Kouhnavard M. Thyroid function tests in critically ill children; any correlation with disease severity or outcome? Iran J Pediatr 2018;28:e69397.
Schmidt-Ott UM, Ascheim DD. Thyroid hormone and heart failure. Curr Heart Fail Rep 2006;3:114-119.
Suvarna JC, Fande CN. Serum thyroid hormone in critically ill children. Indian J Pediatr 2009;76:1217-1221.
Simonides W, Tijsma A, Boelen A, Jongejan R, de Rijke Y, Peeters R, Dentice M, Salvatore D, Muller A. Divergent Thyroid Hormone Levels in Plasma and Left Ventricle of the Heart in Compensated and Decompensated Cardiac Hypertrophy Induced by Chronic Adrenergic Stimulation in Mice. Metabolites 2023;13:308.
WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl 2006;450:76-85.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2018;140:e20171904.
Kowalski RL, Lee L, Spaeder MC, Moorman JR, Keim-Malpass J. Accuracy and Monitoring of Pediatric Early Warning Score (PEWS) Scores Prior to Emergent Pediatric Intensive Care Unit (ICU) Transfer: Retrospective Analysis. JMIR Pediatr Parent 2021;4:e25991.
Auerbach SR, Richmond ME, Lamour JM, Blume ED, Addonizio LJ, Shaddy RE, Mahony L, Pahl E, Hsu DT. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail 2010;3:606-611. Epub 2010 Jun 23
Lerner RK, Gruber N, Pollak U. Congenital Heart Disease and Thyroid Dysfunction: Combination, Association, and Implication. World J Pediatr Congenit Heart Surg 2019;10:604-615.
Guo J, Hong Y, Wang Z, Li Y. Analysis of the Incidence of Euthyroid Sick Syndrome in Comprehensive Intensive Care Units and Related Risk Factors. Front Endocrinol (Lausanne) 2021;12:656641.
Pontes CDN, Rocha JLGD, Medeiros JMR, Santos BFBD, Silva PHMD, Medeiros JMR, Costa GG, Silva IMS, Gomes DL, Santos FM, Libonati RMF. Low T3 syndrome as a prognostic factor in patients in the intensive care unit: an observational cohort study. Rev Bras Ter Intensiva 2022;34:262-271.
Langouche L, Jacobs A, Van den Berghe G. Nonthyroidal Illness Syndrome Across the Ages. J Endocr Soc 2019;3:2313-2325.
Wajner SM, Maia AL. New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne) 2012;3:8.
Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013;1832:2442-2450. Epub 2013 Jan 9
Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25:336-340.
Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8. Epub 2008 Jul 4
Brozaitiene J, Mickuviene N, Podlipskyte A, Burkauskas J, Bunevicius R. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. BMC Cardiovasc Disord 2016;16:45.
Takahashi H, Kashiwagi Y, Nagoshi T, Tanaka Y, Oi Y, Kimura H, Minai K, Yoshimura M. Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure. Sci Rep 2021;11:21865.
Yanni GN, Destariani CP, Lubis AN, Deliana M. Thyroid Hormone Profile in Children with Sepsis: Does Euthyroid Sick Syndrome Exist? Open Access Maced J Med Sci 2019;7:1110-1113.
Miao G, Pang S, Zhou Y, Duan M, Bai L, Zhao X. Low T3 syndrome is associated with 30-day mortality in adult patients with fulminant myocarditis. Front Endocrinol (Lausanne) 2023;14:1164444.
Strich D, Israel A, Edri S, Gillis D. Age and Gender Adjusted FT3 Levels as Novel Predictors of Survival. J Clin Endocrinol Metab 2023;108:3295-3301.
Zhao X, Zhang R, Jiang H, Liu K, Ma C, Bai M, An T, Yao Y, Wang X, Wang M, Li Y, Zhang Y, Zhang J. Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure. BMC Endocr Disord 2021;21:140.
El-Nawawy A, Elwafa RAHA, Khalil Abouahmed A, Rasheed RA, Omar OM. Evaluation of non-thyroidal illness syndrome in shock patients admitted to pediatric intensive care unit in a developing country. Eur J Pediatr 2024;183:769-778. Epub 2023 Nov 23
Carreras L, Riaño I, Vivanco A, Avello N, Iglesias T, Rey C. Non-thyroidal illness syndrome and its relationship with mortality risk in critically ill children. Front Pediatr 2023;11:1142332.
Sciacchitano S, Capalbo C, Napoli C, Anibaldi P, Salvati V, De Vitis C, Mancini R, Coluzzi F, Rocco M. Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses. Front Endocrinol (Lausanne) 2022;13:850328.
Zhang JQ, Yang QY, Xue FS, Zhang W, Yang GZ, Liao X, Meng FM. Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial. Medicine (Baltimore) 2018;97:e12100.
Flores S, Loomba RS, Checchia PA, Graham EM, Bronicki RA. Thyroid Hormone (Triiodothyronine) Therapy in Children After Congenital Heart Surgery: A Meta-Analysis. Semin Thorac Cardiovasc Surg 2020;32:87-95. Epub 2019 May 22


